Abstract
Autism is a developmental disorder that affects communication and behavior. Although autism can be diagnosed at any age, it is said to be a “developmental disorder” because symptoms generally appear in the first 2 years of life. The primary cause of autism is still not clear and therapy is currently restricted to controlling behavioral abnormalities. However, emerging studies have shown a link between mitochondrial dysfunction and autism. Dietary supplements that promote mitochondrial biogenesis and inhibit the production of oxidative stress have been used to treat autism patients. Dietary adjustments in treating autism is a novel approach to suppress autistic symptoms. Supplementation with antioxidants has been found to not only inhibit cognitive decline but also improve behavioral symptoms in autism. Dietary supplements fortified with vitamins should only be given under the supervision of a physician. A wide range of nutraceuticals are under clinical trials to understand whether they physiologically target mitochondrial pathways and improve the quality of life in autism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sanctuary, M. R., Kain, J. N., Angkustsiri, K., & German, J. B. (2018). Dietary considerations in autism spectrum disorders: The potential role of protein digestion and microbial putrefaction in the gut-brain axis. Frontiers in Nutrition, 5, 40. https://doi.org/10.3389/fnut.2018.00040
McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: A meta-analysis. Pediatrics, 133, 872–883. https://doi.org/10.1542/peds.2013-3995
Kawicka, A., & Regulska-Ilow, B. (2013). How nutritional status, diet and dietary supplements can affect autism. A review. Roczniki Państwowego Zakładu Higieny, 64, 1–12.
Rollett, A. (1909). Zur Kenntnis der Linolensäure und des Leinöls. Zeitschrift für physiologische Chemie, 62(5–6), 422–431.
Cheng, Y. S., Tseng, P. T., Chen, Y. W., Stubbs, B., Yang, W. C., Chen, T. Y., et al. (2017). Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: A meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment, 13, 2531–2543. https://doi.org/10.2147/NDT.S147305
Hagmeyer, S., Sauer, A. K., & Grabrucker, A. M. (2018). Prospects of zinc supplementation in autism spectrum disorders and shankopathies such as Phelan McDermid syndrome. Frontiers in Synaptic Neuroscience, 10, 11. https://doi.org/10.3389/fnsyn.2018.00011
Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., et al. (2009). A modern approach to the treatment of mitochondrial disease. Current Treatment Options in Neurology, 11, 414–430.
Gunes, S., Ekinci, O., & Celik, T. (2017). Iron deficiency parameters in autism spectrum disorder: Clinical correlates and associated factors. Italian Journal of Pediatrics, 43, 86. https://doi.org/10.1186/s13052-017-0407-3
Mousain-Bosc, M., Roche, M., Polge, A., Pradal-Prat, D., Rapin, J., & Bali, J. P. (2006). Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnesium Research, 19, 53–62.
Griffiths, K. K., & Levy, R. J. (2017). Evidence of mitochondrial dysfunction in autism: Biochemical links, genetic-based associations, and non-energy-related mechanisms. Oxidative Medicine and Cellular Longevity, 2017, 4314025. https://doi.org/10.1155/2017/4314025
Coleman, M., & Blass, J. P. (1985). Autism and lactic acidosis. Journal of Autism and Developmental Disorders, 15, 1–8.
Lombard, J. (1998). Autism: A mitochondrial disorder? Medical Hypotheses, 50, 497–500.
Bernier, F. P., Boneh, A., Dennett, X., Chow, C. W., Cleary, M. A., & Thorburn, D. R. (2002). Diagnostic criteria for respiratory chain disorders in adults and children. Neurology, 59, 1406–1411. https://doi.org/10.1212/01.wnl.0000033795.17156.00
Correia, C., Coutinho, A. M., Diogo, L., Grazina, M., Marques, C., Miguel, T., et al. (2006). Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: No association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders, 36, 1137–1140. https://doi.org/10.1007/s10803-006-0138-6
Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47, 185–189.
Minshew, N. J., Goldstein, G., Dombrowski, S. M., Panchalingam, K., & Pettegrew, J. W. (1993). A preliminary 31P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes. Biological Psychiatry, 33, 762–773. https://doi.org/10.1016/0006-3223(93)90017-8
Richard E. F, & Daniel A. R. (2011). Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatric Research, 69, 5. https://doi.org/10.1203/PDR.0b013e318212f16b
Chez, M. G., Dowling, T., Patel, P. B., Khanna, P., & Kominsky, M. (2007). Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatric Neurology, 36, 361–365. https://doi.org/10.1016/j.pediatrneurol.2007.01.012
Malik, M., Sheikh, A. M., Wen, G., Spivack, W., Brown, W. T., & Li, X. (2011). Expression of inflammatory cytokines, Bcl 2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology, 216, 80–85. https://doi.org/10.1016/j.imbio.2010.03.001
Kurup, R. K., & Kurup, P. A. (2003). A hypothalamic digoxin-mediated model for autism. The International Journal of Neuroscience, 113, 1537–1559. https://doi.org/10.1080/00207450390231482
Siddiqui, M. F., Elwell, C., & Johnson, M. H. (2016). Mitochondrial dysfunction in autism spectrum disorders. Autism-Open Access, 6, 1000190. https://doi.org/10.4172/2165-7890.1000190
Chauhan, A., Audhya, T., & Chauhan, V. (2012). Brain region-specific glutathione redox imbalance in autism. Neurochemical Research, 37, 1681–1689. https://doi.org/10.1007/s11064-012-0775-4
Rose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., et al. (2012). Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Translational Psychiatry, 2, e134. https://doi.org/10.1038/tp.2012.61
Frye, R. E., & Rossignol, D. A. (2014). Treatments for biomedical abnormalities associated with autism spectrum disorder. Frontiers in Pediatrics, 2, 66. https://doi.org/10.3389/fped.2014.00066
James, S. J., Melnyk, S., Fuchs, G., Reid, T., Jernigan, S., Pavliv, O., et al. (2009). Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. The American Journal of Clinical Nutrition, 89, 425–430. https://doi.org/10.3945/ajcn.2008.26615
Bremer, J. (1983). Carnitine–metabolism and functions. Physiological Review, 63, 1420–1479.
Cannan, R. K., & Shore, A. (1928). The creatine-creatinine equilibrium. The apparent dissociation constants of creatine and creatinine. Biochemical Journal, 22(4), 920–929.
Crane, F. L. (2007). Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion, 7(Suppl), S2–S7.
Apel, F. (2015, July). Biographie von Ernst Schulze. http://www.arginium.de/wp-content/uploads/2015/09/Biographie-Ernst-Schulze-Juli-2015.pdf.
Tein, I. (2003). Carnitine transport: Pathophysiology and metabolism of known molecular defects. Journal of Inherited Metabolic Disease, 26, 147–169.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chidambaram, S.B. et al. (2020). Protein Nutrition in Autism. In: Essa, M., Qoronfleh, M. (eds) Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Advances in Neurobiology, vol 24. Springer, Cham. https://doi.org/10.1007/978-3-030-30402-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-30402-7_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30401-0
Online ISBN: 978-3-030-30402-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)